Improvement of Nephrotoxicity, Hypertension, and Lipid Metabolism After Conversion of Kidney Transplant Recipients From Cyclosporine to Tacrolimus

By Friemann S.   Feuring E.   Padberg W.   Ernst W.  

Transplantation Proceedings, Vol. 30, Iss. 4, 1998-06 ,pp. : 1240-1242

Elsevier

Access to resources Recommend Favorite

Effect of conversion from cyclosporine to tacrolimus on lipid profiles in renal transplant recipients

By Colak T.   Karakayali H.   Yagmurdur M.C.   Moray G.  

Transplantation Proceedings, Vol. 34, Iss. 6, 2002-09 ,pp. : 2081-2082

Elsevier

Access to resources Recommend Favorite

Conversion From Neoral (Cyclosporine) to Tacrolimus of Kidney Transplant Recipients for Gingival Hyperplasia or Hypertrichosis

By Busque S.   Demers P.   St-Louis G.   Boily J.-G.   Tousignant J.   Lemieux F.   Smeesters C.   Corman J.   Daloze P.  

Transplantation Proceedings, Vol. 30, Iss. 4, 1998-06 ,pp. : 1247-1248

Elsevier

Access to resources Recommend Favorite

Conversion from cyclosporine to tacrolimus is preferred by pediatric renal transplant recipients: a focus on opinions and outcomes

By Sundberg A.K.   Smith L.D.   Somerville K.T.   Cox R.   Sherbotie J.R.  

Transplantation Proceedings, Vol. 34, Iss. 5, 2002-08 ,pp. : 1951-1952

Elsevier

Access to resources Recommend Favorite

Conversion from cyclosporine to tacrolimus for refractory acute rejection in pediatric kidney transplant recipients: a single-center experience

By Ferraresso M.   Ghio L.   Edefonti A.   Garavaglia R.   Pozzoli E.   Berardinelli L.  

Transplantation Proceedings, Vol. 33, Iss. 7, 2001-11 ,pp. : 3590-3591

Elsevier

Access to resources Recommend Favorite